2013
DOI: 10.1016/j.phymed.2012.11.003
|View full text |Cite
|
Sign up to set email alerts
|

Achyrofuran is an antibacterial agent capable of killing methicillin-resistant vancomycin-intermediate Staphylococcus aureus in the nanomolar range

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
16
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 23 publications
(17 citation statements)
references
References 18 publications
1
16
0
Order By: Relevance
“…Many bacterial pathogens associated with epidemics of gastrointestinal tract disorders in humans, such as Escherichia coli , Salmonella spp., and Staphylococcus aureus , have evolved multidrug-resistant forms subsequent to antibiotic use [ 1 ]. The extensive use of antibiotics over the last decade has led to the emergence of bacterial resistance and the dissemination of resistant genes among pathogenic microorganisms [ 2 ]. In recent years, several associations between common chronic human disorders and an altered composition and function of the gut microbiome have been reported [ 3 6 ].…”
Section: Introductionmentioning
confidence: 99%
“…Many bacterial pathogens associated with epidemics of gastrointestinal tract disorders in humans, such as Escherichia coli , Salmonella spp., and Staphylococcus aureus , have evolved multidrug-resistant forms subsequent to antibiotic use [ 1 ]. The extensive use of antibiotics over the last decade has led to the emergence of bacterial resistance and the dissemination of resistant genes among pathogenic microorganisms [ 2 ]. In recent years, several associations between common chronic human disorders and an altered composition and function of the gut microbiome have been reported [ 3 6 ].…”
Section: Introductionmentioning
confidence: 99%
“…One apparently feasible approach to the problem is to develop new antibacterial agents present in a high number of sources, such as plant-derived extracts and compounds (Michielin et al 2009). Currently, there are many other extracts and (or) compounds isolated from plants that have anti-MRSA activities (Zoraghi et al 2011;Casero et al 2013;Patel et al 2013). However, many of these agents are difficult to obtain or not very effective against MRSA clinical strains.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, methicillin-resistant Staphylococcus aureus (MRSA) has developed as the predominant pathogenic bacterium of hospital infections, leading to high morbidity and mortality (Andersson and Hughes 2010;Casero et al 2013). The ␤-lactam antibiotics have been the effective agents against staphylococcal infections prior to the emergence of MRSA, but resistance to antibiotics (including ␤-lactams) is increasing because of the uncontrolled use of antibiotics (Villegas-Estrada et al 2008).…”
Section: Introductionmentioning
confidence: 99%
“…For example, methyl angolensate, a compound isolated from the Indian plant Soymida febrifuga, has the same structural motifs as secochiliolide acid, and displayed antibacterial, antifungal and insect antifeedant properties (Samir et al, 2001;Chiruvella et al, 2007). Also, benzofurans, furanocoumarins, furoflavones, furanochalcones and furanoterpenes, all of which share with compound 1 a furan ring moiety, and can be isolated from terrestrial plants, have shown a broad range of biological activities such as antibacterial and antifungal properties (Sardari et al, 2000;DellaGreca et al, 2001;Waridel et al, 2003;Widelski et al, 2009;Alam and Lee, 2011;Kamal et al, 2011;Tran et al, 2012;Casero et al, 2013). In particular, imperatorin, a furanocoumarin, showed high inhibitory activity against larval settlement of Balanus albicostatus (Wang et al, 2013).…”
Section: Discussionmentioning
confidence: 99%